ArticleBMC biotechnology2021

Screening of miRNAs in plasma as a diagnostic biomarker for cardiac disease based on optimization of extraction and qRT-PCR condition assay through amplification efficiency.

Eunmi Ban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.